Treatment Phenotypes for Adolescents With Asthma

This study will look at how adolescents use both their controller and rescue medications using an electronic medication monitoring platform, for the period of one year. Participants will be enrolled in a medication monitoring platform, and their asthma care provider will have access to medication usage information. The study team will collect data on medication use patterns in a real world setting for 12 months per participant. Additionally, healthcare providers will be enrolled in focus groups to determine barriers and facilitators to optimal medication use for their patients.

For adolescent participants:

Inclusion criteria

• Diagnosis of asthma On an inhaled controller and rescue medication for which a propeller health device is available

Exclusion criteria

• Other significant chronic lung disease (from problem list)

• Cystic fibrosis
• Chronic respiratory failure
• Tracheostomy status
• Intersititial lung disease
• Significant developmental delay
• Taking more than 3 asthma related medications
• Primary language other than English, Spanish, Catalan, Dutch, French, German or Italian

Healthcare providers will be recruited as well to participate in focus groups as part of specific aim 2.